EXPRESSION OF TOXOPLASMA RECOMBINANT PLASMID IN MAMMALIAN CELLS

JIANG Yuan,GU Qin-min,LI Ying,ZHOU Huai-yu,Zhao Qun-li
DOI: https://doi.org/10.3969/j.issn.1673-5234.2005.04.003
2005-01-01
Abstract:Objective To study the eukaryotic expression of the recombinant plasmid pcDNA3.1-P30-P22-CTXA_2/B in mammalian cells. Methods The eukaryotic expression plasmids pcDNA3.1-P30-P22-CTXA_2/B and pcDNA3.1 were transfected into Hela cells respectively with liposome according to the manufacturer's protocol. In order to generate stable transfectants, after a 48 h incubation period in regular Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 10% heat inactivated fetal calf serum, cells were selected by neomycin (400 μg/ml of G418) and maintained with neomycin (200 μg/ml of G418). G418-resistant colonies, which became visible after 2 weeks, were isolated and screened for expression of the vector encoding protein. The control transfections were performed with the pcDNA3.1 vector without recombinant. The expression product of the insertional genes were analysed by SDS-PAGE and Western-blot. The cells transfected by pcDNA3.1 were used as the negative control. Results The expression plasmid showed one protein band at 64 ku site compared with the negative control by SDS-PAGE. The result of Western-blot proved that the compound protein can be identified by P30 antibody. Conclusion The eukayotic expression plasmid pcDNA3.1-P30-P22-CTXA_2/B can express fusion protein product which were encoded by insertional gene P30-P22-CTXA_2/B in mammalian cells.
What problem does this paper attempt to address?